FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137352804> ?p ?o ?g. }

• W2137352804 abstract "In Europe most dogs with clinical leishmaniosis are treated with leishmanicides, typically antimonials combined with allopurinol and good clinical recovery is observed in a high number of these dogs. Through xenodiagnosis, the capacity of a treated animal to infect the vector of the disease under treatment is assessed as a measure of the chemotherapeutic efficacy of the drug used. The objective of the present study was to evaluate through direct xenodiagnosis the infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after treatment, and to follow the clinical and parasite course of disease. Thirty two dogs with clinical leishmaniosis were assigned to one of three treatment groups: meglumine antimoniate plus allopurinol (Group A), meglumine antimoniate (Group B) or allopurinol (Group C). During the study, the dogs were examined before treatment (Day 0) and bimonthly thereafter until Day 180 (six months post-treatment onset). The three groups were scored over time according to the effects of treatment on clinical signs and clinical-pathological variables. Significant differences in clinical scores were observed between Group A and the other two groups, indicating the combined treatment was the most effective. After treatment, bone marrow cultures were positive for the parasite in 30.8% of dogs in some of the check ups (3 or 25% in Group A, 1 or 11.1% in Group B, and 4 or 80% in Group C). Our xenodiagnosis experiments revealed that 15.4% of treated dogs were still able to infect sand flies at some point after treatment (2 dogs or 16.6% in Group A, 2 or 22.2% in Group B and none in Group C). Only 7.7% of the entire study population could infect sand flies as from the second month post-treatment onset. The three treatment regimens tested significantly reduced the infectivity of dogs towards sand flies, thus diminishing the epidemiological risks of treated dogs both for human beings and other healthy dogs. Despite its low cure rate, the use of allopurinol after a course of leishmanicide treatment is proposed to keep dogs non-infectious during the disease transmission season (4-6 months in southern Europe)." @default.
• W2137352804 created "2016-06-24" @default.
• W2137352804 creator A5003727204 @default.
• W2137352804 creator A5035395713 @default.
• W2137352804 creator A5040839341 @default.
• W2137352804 creator A5044803305 @default.
• W2137352804 creator A5048253790 @default.
• W2137352804 date "2011-04-13" @default.
• W2137352804 modified "2023-10-01" @default.
• W2137352804 title "Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments" @default.
• W2137352804 cites W1772992353 @default.
• W2137352804 cites W1963508090 @default.
• W2137352804 cites W1969932678 @default.
• W2137352804 cites W1977450241 @default.
• W2137352804 cites W1979361572 @default.
• W2137352804 cites W1980967470 @default.
• W2137352804 cites W1984594388 @default.
• W2137352804 cites W1985088770 @default.
• W2137352804 cites W1995725063 @default.
• W2137352804 cites W2006045262 @default.
• W2137352804 cites W2014670730 @default.
• W2137352804 cites W2022577388 @default.
• W2137352804 cites W2041168430 @default.
• W2137352804 cites W2041721001 @default.
• W2137352804 cites W2050159846 @default.
• W2137352804 cites W2056867292 @default.
• W2137352804 cites W2066439892 @default.
• W2137352804 cites W2080370913 @default.
• W2137352804 cites W2092367090 @default.
• W2137352804 cites W2093547754 @default.
• W2137352804 cites W2093557430 @default.
• W2137352804 cites W2106094279 @default.
• W2137352804 cites W2128166966 @default.
• W2137352804 cites W2128835407 @default.
• W2137352804 cites W2131902485 @default.
• W2137352804 cites W2144263602 @default.
• W2137352804 cites W2151563447 @default.
• W2137352804 cites W3028112943 @default.
• W2137352804 cites W4211253687 @default.
• W2137352804 cites W76674196 @default.
• W2137352804 doi "https://doi.org/10.1186/1756-3305-4-52" @default.
• W2137352804 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3094395" @default.
• W2137352804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21489241" @default.
• W2137352804 hasPublicationYear "2011" @default.
• W2137352804 type Work @default.
• W2137352804 sameAs 2137352804 @default.
• W2137352804 citedByCount "56" @default.
• W2137352804 countsByYear W21373528042012 @default.
• W2137352804 countsByYear W21373528042013 @default.
• W2137352804 countsByYear W21373528042014 @default.
• W2137352804 countsByYear W21373528042015 @default.
• W2137352804 countsByYear W21373528042016 @default.
• W2137352804 countsByYear W21373528042017 @default.
• W2137352804 countsByYear W21373528042018 @default.
• W2137352804 countsByYear W21373528042019 @default.
• W2137352804 countsByYear W21373528042020 @default.
• W2137352804 countsByYear W21373528042021 @default.
• W2137352804 countsByYear W21373528042022 @default.
• W2137352804 countsByYear W21373528042023 @default.
• W2137352804 crossrefType "journal-article" @default.
• W2137352804 hasAuthorship W2137352804A5003727204 @default.
• W2137352804 hasAuthorship W2137352804A5035395713 @default.
• W2137352804 hasAuthorship W2137352804A5040839341 @default.
• W2137352804 hasAuthorship W2137352804A5044803305 @default.
• W2137352804 hasAuthorship W2137352804A5048253790 @default.
• W2137352804 hasBestOaLocation W21373528041 @default.
• W2137352804 hasConcept C106358424 @default.
• W2137352804 hasConcept C126322002 @default.
• W2137352804 hasConcept C136764020 @default.
• W2137352804 hasConcept C203014093 @default.
• W2137352804 hasConcept C2522874641 @default.
• W2137352804 hasConcept C2776555147 @default.
• W2137352804 hasConcept C2777625466 @default.
• W2137352804 hasConcept C2777785397 @default.
• W2137352804 hasConcept C2778335811 @default.
• W2137352804 hasConcept C2778689377 @default.
• W2137352804 hasConcept C2780261098 @default.
• W2137352804 hasConcept C2780423678 @default.
• W2137352804 hasConcept C2781092759 @default.
• W2137352804 hasConcept C2781257258 @default.
• W2137352804 hasConcept C41008148 @default.
• W2137352804 hasConcept C71924100 @default.
• W2137352804 hasConcept C71928629 @default.
• W2137352804 hasConcept C86803240 @default.
• W2137352804 hasConceptScore W2137352804C106358424 @default.
• W2137352804 hasConceptScore W2137352804C126322002 @default.
• W2137352804 hasConceptScore W2137352804C136764020 @default.
• W2137352804 hasConceptScore W2137352804C203014093 @default.
• W2137352804 hasConceptScore W2137352804C2522874641 @default.
• W2137352804 hasConceptScore W2137352804C2776555147 @default.
• W2137352804 hasConceptScore W2137352804C2777625466 @default.
• W2137352804 hasConceptScore W2137352804C2777785397 @default.
• W2137352804 hasConceptScore W2137352804C2778335811 @default.
• W2137352804 hasConceptScore W2137352804C2778689377 @default.
• W2137352804 hasConceptScore W2137352804C2780261098 @default.
• W2137352804 hasConceptScore W2137352804C2780423678 @default.
• W2137352804 hasConceptScore W2137352804C2781092759 @default.
• W2137352804 hasConceptScore W2137352804C2781257258 @default.
• W2137352804 hasConceptScore W2137352804C41008148 @default.
• W2137352804 hasConceptScore W2137352804C71924100 @default.

• next